Общность патогенетических механизмов развития хронического панкреатита 4 страница

89. De Reggi M., Capon C, Gharib B. et al. The glycan moiety of human pancreatic lithostath­
ine. Structure characterization and possible pathophysiological implications // Eur. J. Bio­
chem.— 1995.—Vol.230.- P.503—510.

90. De Reggi M., Gharib В., Patard L., Sloven V. Lithostathine, the presumed pancreatic stone
inhibitor, does not interact specifically with calcium carbonate crystals // J. Biol. Chem.—

1998.- Vol.273.- P.4967-4971.

91. Demols A., Le Moine O., Desalle F. et al. CD4(+)T cells play an important role in acute ex­
perimental pancreatitis in mice // Gastroenterol.—2000.—Vol.118.— P.582—590.

92. Demols A., Deviere J. New frontiers in the pharmacological prevention of post-ERCP
pancreatitis: The Cytokines // JOP. J. Pancreas (Online).— 2003.—Vol. 4 (1).— P 49—
57.

93. Denham W., Yang J., Fink G. et al. TNF but not IL-1 decreases pancreatic acinar cell sur­
vival without affecting exocrine function: a study in the perfused human pancreas // J.
Surg. Res.— 1998.—Vol. 74 (1).—P.3-7.

94. Denham W., Norman J. The proteinal role of therapeutic cytokine manipulation in acute
pancreatitis // Surg. Clin. North. Am.— 1999.—Vol. 79 (4).— P.767—781.

95. Deviere J., Le Moine O., Van Laethem J. L. et al. IL-10 reduces the incidence of pancrea­
titis after therapeutic endoscopic retrograde cholangiopancreatography // Gastroenterol.—
2001.-Vol. 120 (2).-P.498-505.

96. Di Mola F. F., Friess H., Martignoni M. E. et al. Connective tissue growth factor is a regu­
lator for fibrosis in human chronic pancreatitis // Ann. Surg.—1999.—Vol. 230 (1).—
P.63-71.

97. Di Sebastiano P., di Mola F. F., Di Febbo F. F. et al. Expression of IL-8 and substance P in
human chronic pancreatitis // Gut.— 2000.— Vol. 47 (3).— P.432—428.

98. DiMagno E. P., Go V. L. M., Summerskill W. H. J. Relation as between pancreatic enzyme
outputs and malabsorption in severe pancreatic insufficiency // N. Engl. J. Med.— 1973.—
Vol. 288.-P.813-815.

99. DiMagno E. P., Malagalada J. R., Go V. L. M. Fate of orally ingested enzymes in pancre­
atic insufficiency // Comparison of two dosage schedules // N. Engl. J. Med.— 1977.—
Vol. 296.— P.1318—1322.

100. Drickamer K, Taylor M. E. Biology of animal lectins // Annu. Rev. Cell. Biol.— 1993.—
Vol.9.— P.237—264.

101. Dugernier Т., Laterre P. F., Reynaert M. S. Ascites fluid in severe acute pancreatiis: from
pathophysiology to therapy // Acta. Gastroenterol. Belg.—2000.—Vol. 63 (3).—P.264—
268.

102. Dumot J. A., Conwell D. L., Zuccaro G. Jr. et al. A randomized, double blind study of IL-
10 for the prevention of ERCP-induced pancreatitis // Am. J. Gastroenterol.—2001.—
Vol. 96 (7).— P.2098-2102.

103. Dunn J. A., Li С, На Т., Kao R. L., Browder W. Therapeutic modification of nuclear fac­
tor kappa В binding activity and tumor necrosis factor-alpha gene expression during acute
biliary pancreatitis // Am. Surg.— 1997.—Vol.63.— P. 1036—1043.

104. Dutta S., Hubbard V., Appier M. Critical evaluation of the therapeutic efficacy of a pH sen­
sitive enteric-coated pancreatic enzyme preparation in the treatment of exocrine pancreatic

162 • ХРОНИЧЕСКИЙ ПАНКРЕАТИТ

insufficiency secondary to cystic fibrosis // Dig. Dis. Sci.—1988.—Vol. 33.—P. 1237— 1244.

105. Emmrich J., Seyfarth M., Conradi P. et al. Secretory immunoglobulin A in pancreatic juice
and pancreatic tissue of patients with chronic pancreatitis // Gut.— 1998.—Vol. 42 (3).—
P.436-441.

106. Ewart K. V., Li Z, Yang D. S. С et al. The ice-binding site of atlantic herring antifreeze
protein corresponds to the carbohydrate-binding site of C-type lectins // Biochemistry.—
1998.-Vol.37.- P.4080-4085.

107. Fedail S. S., Harvey R. F., Salmon P. R. et al. Trypsin and lactoferrin levels in pure pancre­
atic juice in patients with pancreatic disease // Gut.— 1979— Vol. 20,— P.983—986.

108. Figarella C, Vogt E., Hosli P. Alkaline phosphatase and acid lysosomal hydrolases in pan­
creatic juice and fibroblast cell cultures of patients with chronic calcifying pancreatitis //
Eur. J. Clin. Invest.— 1982.- Vol.12.- P.145-149.

109. Figarella C, Amouric M., Guy-Crotte O. Proteloysis of human trypsinogen 1. Pathogenic
implication in chronic pancreatitis // Biochem. Biophys. Res. Commun.— 1984.—
Vol.118.— P.154—161.

110. Figarella C, Miszczuk-Jamska В., Barrett A. Possibile lysosomal activation of pancreatic zy-
mogens. Activation of both human trypsinogens by cathepsin В and spontaneous acid. Ac­
tivation of human trypsinogen-1 // Biol. Chem. Hoppe-Seyler.— 1988.— Vol.369.—
P.293—298.

111. Fogar P., Pasquali C, Basso D. et al. Transforming growth factor beta, fibrogenesis and hy-
perglycemia in patients with chronic pancreatitis // J. Med,— 1998.—Vol. 29 (5—6).—
P.277-287.

112. Frossard J. L. Trypsin activation peptide (TAP) in acute pancreatitis: from pathophysiology
to clinical usefulness // JOP. J. Pancreas (Online).- 2001.— Vol. 2 (2).— P. 69—77.

113. Fyssas I., Syrigos K. N., Konstandoulakis M. M. et al. Sex hormone levels in the serum if
patients with pancreatic adenocarcinoma // Horm. Metab. Res.—1997.—Vol.29 (3).—
P.115—118.

114. Geider S., Baronnet A., Cerini С et al. Pancreatic lithostathine as a calcite habit modifier /
/ J. Biol. Chem.- 1996.- Vol. 271.- P. 2632-2636.

115. Geokas M. C, Rinderknecht H. Free proteolytic enzymes in pancreatic juice of patients
with acute pancreatitis // Am. J. Dig. Dis.— 1974.—Vol. 19.— P. 591—598.

116. Gerbaud V., Pignol D., Loret E. et al. Mechanism of calcite crystal growth inhibition by the
N-terminal undecapeptide of lithostathine // J. Biol. Chem.—2000.—Vol. 275.—
P.1057—1064.

117. Gharib В., Fox M. F., Bartoli С et al. Human regeneration protein/lithostathine genes map
to chromosome 2pl2 // Ann. Hum. Genet.— 1993.—Vol. 57.— P.9—16.

118. Gloor В., Blinman T. A., Rigberg D. A. et al. Kupffer cell blockade reduces hepatic and sys­
temic cytokine levels and lung injury in hemorrhagic pancreatitis in rats // Pancreas.—
2000.-Vol. 21.-P.414-420.

119. Gloor В., Todd К. Е., Lane J. S. et al. Hepatic Kupffer cell blockade reduces mortality of
acute hemorrhagic pancreatitis in mice // J. Gastrointest. Surg.— 1998,—Vol.2.— P.430—
435.

120. Gough D. В., Boyle В., Joyce W. P. et al. Free radical inhibition and serial chemimmines-
cence in evolving experimental pancreatitis // Br. J. Surg.— 1990.—Vol. 77.— P. 1256—
1259.

121. Graf R., Schiesser M., Scheele G. A. et al. A family of 16-kDa pancreatic secretory stress
proteins form highly organized fibrillar structures upon tryptic activation // J. Biol.
Chem.—2001.-Vol.276.-P.2128-2138.

122. Graves B. J., Crowther R. L., Chandran С et al. Insight into E-selectin/ligand interaction
from the crystal structure and mutagenesis of the lec/EGF domains // Nature.— 1994.—
Vol.367.- P.532-538.

123. Greenbaum L. M., Hirshkowitz A., Stoichet I. The activation of trypsinogen by cathepsin В
// J. Biol. Chem.- 1959.-Vol.234.- P.2885-2890.

124. Greenbaum L. A., Hirshkowitz A. Endogenous cathepsin activates trypsinogen in extracts of
dog pancreas // Proc. Soc. Exp. Biol. Med.- 1961.-Vol.107.—P.74—76.

125. Gross J., Brauer A. W., Bringhurst R. F. et al. An unusual bovine pancreatic protein exhib­
iting pH-dependent globule-fibril transformation and unique amino acid sequence // Proc.
Natl. Acad. Sci. USA.- 1985.-Vol.82.-P. 5627-5631.

126. Gross J., Carlson R. I., Brauer A. W. et al. Isolation, characterization, and distribution of
an unusual pancreatic human secretory protein // J. Clin. Invest.— 1985.— Vol.76.—
P.2115—2126.

Глава 3. Универсальные патогенетические механизмы развития ХП • 163

127 Gukovsky I., Gukovskaya A. S., Blinman T. A. et al. Early NF-kappaB activation is associ­ated with hormone-induced pancreatitis // Am. J. Physiol.— 1998.—Vol.275.— P. 1402—

1414.

128. Cuy o., Robtes-Diaz о., Aidrich Z. et al. Protein content If precipitates present in pancre­
atic juice of alcoholic subjects and patients with chronic calcifying pancreatitis // Gastro-
enterology.- 1983.- Vol.84.- P.102-107.

129. Hakansson K., Lim N. K., Hoppe H. J., Reid K. B. Crystal structure of the trimeric alpha-
helical coiled-coil and the three lectin domains of human lung surfactant protein D //
Structure Fold. Des,— 1999,-Vol.7,- P.255—264.

130. Halangk W., Lerch M. M., Brandt-Nedelev B. et al. Role of cathepsin В in intracellular
trypsinogen activation and the onset of acute pancreatitis // J. Clin. Invest.— 2000.—
Vol.106.-P.773-781.

131. Han В., Logsdon С D. Cholecystokinin induction of mob-1 chemokine expression in pan­
creatic acinar cells requires NF-kappaB activation // Am. J. Physiol.— 1999.—Vol.277.—
P.74-82.

132. Harada H., Takeda M., Tanaka J. et al. The fine structure of pancreatic stones as shown by
scanning electron microscopy and X-ray probe microanalyser // Gastroenterol. Jpn.—
1983.-Vol.18.-P.530-537.

133. Hartwig W., Jimenez R. E., Werner J. et al. Interstitial trypsinogen release and its relevance
to the transformation of mild into necrotizing pancreatitis in rats // Gastroenterol.—
1999.— Vol.117.— P.717—725.

134. Hayakawa Т., Harada H., Noda A., Kondo T. Lactoferrin in pure pancreatic juice in chron­
ic pancreatitis // Am. J. Gastroenterol.— 1983.— Vol.78.— P. 222—244.

135. Hayakawa Т., Kondo Т., Shibata T. et al. Secretory component and lactoferrin in pure pan­
creatic juice in chronic pancreatitis // Dig. Dis. Sci. —1993.—Vol.38.— P.7—11.

136. Hayakawa Т., Kondo Т., Shibata T. et al. Trypsinogen content of pancreatic calculi in
chronic calcified pancreatitis in man // Dig. Dis. Sci.— 1994.— Vol.39.— P.1345—1350.

137. Hayakawa Т., Naruse S., Kitagawa M. et al. Pancreatic stone protein and lactoferrin in hu­
man pancreatic juice in chronic pancreatitis // Pancreas. —1995.—Vol.10.— P. 137—142.

138. Hekman A. Association of lactoferrin with other proteins, as demonstrated by changes in
electrophoretic mobility// Biochim. Biophys. Acta,— 1971.—Vol. 251.— P.380—387.

139. Hietaranta A. J., Saluja A. K, Bhagat L. et al. Relationship between NF-kappaB and
trypsinogen activation in rat pancreas after supramaximal caerulein stimulation // Bio-
chem. Biophys. Res. Commun.—2001.—Vol.280.—P.388—395.

140. Hirota M., Nozawa F., Okabe A. et al. Relationship between plasma cytokine concentration
and multiple organ failure in patients with acute pancreatitis // Pancreas.— 2000.— Vol 21
(2).-P.141-146.

141. Ho/batter В., Saluja A. K, Lerch M. M. et al. Intra-acinar cell activation of trypsinogen
during cerulein-induced pancreatitis in rats // Am. J. Physiol.— 1998.— Vol.275.— P.352—
362.

142. Iba K, Durkin M. E., Johnsen L. et al. Mice with a targeted deletion of the tetranectin gene
exhibit a spinal deformity// Mol. Cell. Biol.—2001.—Vol.21.— P.7817—7825.

143. Ihse I., Arnesjoe В., Kugelberg С et al. Intestinal activities of trypsin, lipase and phospholi-
pase after a test meal. An evaluation of 474 examination // Scand. J. Gastroenterol.—
1977.-Vol.12.-P.663-668.

144. lovanna J., Frigerio J. M., Dusetti N. et al. Lithostathine, an inhibitor of СаСОЗ crystal
growth in pancreatic juice, induces bacterial aggregation // Pancreas.— 1993.— Vol.8.—
P.597-601.

145. Isaksson G., Ihse I. Pain reduction by an oral pancreatic enzyme preparation in chronic
pancreatitis // Dig. Dis. Sci.- 1983.- Vol.28.- P.97-102.

146. Jin C, Ni Q., Zhang Q. Apoptosis of pancreatic acinar and expression of TNF-б mRNA,
IL-10 mRNA in rats with acute pancreatitis // Zhonghua Wai. Ke. Za. Zhi.— 2001.—
Vol. 39 (8).- P.626-628.

147. Jin С X., Naruse S., Kitagawa M. et al. Pancreatic stone protein of pancreatic calculi in
chronic calcified pancreatitis in man // JOP. J. Pancreas. (Online).— 2002.— Vol. 3 (2).—

P. 54—61.

148. Kastrup J. S., Nielsen В. В., Rasmussen H. et al. Structure of the C-type lectin carbohydrate
recognition domain of human tetranectin // Acta. Crystallogr. D. Biol. Crystallogr.—
1998.-Vol.54.- P.757-766.

149. Katsuzaki Т., Tatemichi N., Takeichi С et al. Enzyme immunoassay for specific analysis of
pancreatic stone ptroteins in human pancreatic juice // J. Clin. Lab. Anal.— 1992 —
Vol.6.— P.375—378.

164 • ХРОНИЧЕСКИЙ ПАНКРЕАТИТ

150. Kaw M., Singh S. Serum lipase, C-reactive protein, and interleukin-6 levels in ERCP-in-
duced pancreatitis // Gastrointest. Endosc— 2001.— Vol. 54 (4).— P.435—440.

151. Kazbay K., Tarnavsky P. R., Hawes R. H. et al. Increased transforming growth factor beta
in pure pancreatic juice in pancreatitis // Pancreas,— 2001,—Vol. 22 (2).— P.193—195.

152. Koepell G., Maillet B. Pseudocysts in chronic pancreatitis: a morphological analysis of 57
resection specimens and 9 autopsy pancreata // Pancreas.— 1991. —Vol.6.— P.266—274.

153. Koike H., Steer M. L., Meldolesi J. Pancreatic effects of ethionine: blockade of exocytosis
and appearance of crinophagy and autophagy precede cellular necrosis // Am. J. Physiol.—

1982.- Vol.242.- P.297-307.

154. Konishi K., Izumi R., Kato O. et al. Experimental pancreatolithiasis in the dog // Surgery.—
1981.—Vol.89.— P.687-691.

155. Kornmann M., Ishiwata Т., Arber N. et al. Increased cyclin Dl expression in chronic pan­
creatitis // Pancreas.- 1998.-Vol. 17 (2).- P. 158-162.

156. Lankisch P. C, Creutzfeldt W. Therapy of exocrine and endocrine pancreatic insufficien­
cy.—In Creutzfeldt W., ed. Clinics in Gastroenterology.—Philadelphia: W. B. Saunders,
1984.- P. 985-999.

157. Lankish P. G., Lohr-Happe A., Otto J., Creutzfeldt W. Natural course in chronic pancreati­
tis: pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease //
Digestion,-1993.-Vol.54.-P. 148-155.

158. Lankisch P. G. Progression from acute to chronic pancreatitis: a physician's view // Surg.
Clin. North Am.- 1999.-Vol. 79 (4).- P. 815-827.

159. Larsen S., Pedersen N., Seidelin J., Nielsen H. 0. Alcohol modulates circulating levels of
interleukin-6 and monocyte chemotactic protein-1 in chronic pancreatitis // Gut—
2003.—Vol.52 (suppl.6).- P.174.

160. Lerch M. M., Saluja A. K., Runzi M. et al. Pancreatic duct obstruction triggers acute necro-
tizing pancreatitis in opossum // Gastroenterol.— 1993.—Vol.104.— P.853—861.

161. Lin Y., Tamakoshi A., Hayakawa T. et al. Research Committee on Intractable Pancreatic
Diseases. Associations of alcohol drinking and nutrient intake with chronic pancreatitis:
findings from a case-control study in Japan //Am. J. Gastroenterol.— 2001.— Vol.96 (9).—

P.2622-2627.

162. Lohse J., Kraemer R. Calcium binding to the «stone protein» isolated from pancreatic
stones of patients with chronic calcified pancreatitis // Hoppe Seylers. Z. Physiol. Chem.—

1984.- Vol.365.- P.549-554.

163. Luttenberger Т., Schmid-Kotsas A., Menke A. et al. Platelet-derived growth factors stimulate
proliferation and extracellular matrix synthesis of pancreatic stellate cells: implicatins in
pathogenesis of pancreas fibrosis // Lab. Invest.— 2000.—Vol. 80 (1).— P.47—55.

164. Mandi Y., Farkas G., Takacs T. et al. Diagnostic relevance of procalcitonin, IL-6, and sl-
CAM-1 in the prediction of infected necrosis in acute pancreatitis // Int. J. Pancreatol.—
2000,—Vol. 28 (1).—P.41—49.

165. Mann K., Siedler F. The amino acid sequence of ovocleidin 17, a major protein of the avian
eggshell calcified layer// Biochem. Mol. Biol. Int.— 1999.—Vol.47.— P.997—1007.

166. Mariani A., Bernard J. P., Provansal-Cheylan M. et al. Differences of pancreatic stone mor­
phology and content in patients with pancreatic lithiasis // Dig. Dis. Sci.— 1991.—
Vol.36.— P.1509—1516.

167. Marotta F., Tajiri H., Li Z. L. et al. Pure pancreatic juice from patients with chronic pan­
creatitis has an impaired antibacterial activity // Int. J. Pancreatol.—1997.—Vol.22.—
P.215-220.

168. Mayer J., Rau В., Gansauge F. et al. Inflammatory mediators in human acute pancreatitis:
clinical and pathophysiological implications // Gut.— 2000.—Vol. 47 (4).— P.546—552.

169. Menke A., Geerlingl., Giehl K. et al. Transforming growth factor-beta-induced upregulation
of transforming growth factor-beta receptor expression in pancreatic regeneration // Bio-
chim. Biophys. Acta.- 1999.-Vol. 8 (2).-P. 178-185.

170. Messmann H., Vogt W., Folk W. et al. Interleukins and their antagonists but not TNF and
its receptors are released in post-ERP pancreatitis // Eur. J. Gastroenterol. Gepatol,—
1998.—Vol. 10 (7).—P.611—617.

171. Miszcznk-Janska В., Guy O., Figarella С Alfa 1-Proteinase inhibitor in pure human pan­
creatic juice. Characterization of a complexes form in patients with chronic calcifying pan­
creatitis and its significance // Hoppe Seyler's Z. Physiol. Chem.—1983.—Vol.364.-
P.1597-1601.

172. Montalto G., Multigner L., Sarles H., De Caro A. Les inhibiteurs protftiques de cristallisa-
tion. Caractftrisation et гф1е potentiel dans les lithiases calciques // Nviphrologie.— 1984.—
Vol.5.-P.155-157.

Глава 3. Универсальные патогенетические механизмы развития ХП • 165

173. Moore F. A., Moore E. E. Evolving concept in the pathogenesis of post injury multiple or­
gan failure // Surg. Clin. North. Am,- 1995.-Vol.75.- P.257-277.

174. Morris-Stiff G. J., Bowrey D. J., Oleesky D. The antioxidant profiles of patients with recur­
rent acute and chronic pancreatitis // Am. J. Gastroenterol.—1999.—Vol. 94 (8).—
P.2135—2140.

175. Midler J. M., Rupee R. A., Baeuerle P. A. Study of gene regulation by NF-kappa В and AP-
1 in response to reactive oxygen intermediates // Methods.— 1997.— Vol.11.— P.301—312.

176. Multigner L., Figarella C, SahelJ., Sarles H. Lactoferrin and albumin in human pancreatic
juice: a valuable test for diagnosis of pancreatic diseases // Dig. Dis. Sci,— 1980.—
Vol.25.— P.173— 178.

177. Multigner L., De Caro A., Lombardo D., Campese D., Sarles H. Pancreatic stone protein, a
phosphoprotein which inhibits calcium carbonate precipitation from human pancreatic
juice // Biochem. Biophys. Res. Commun.— 1983.— Vol.110.— P.69—74.

178. Multigner L., Daudon M., Montalto G. et al. Radiolucent pancreatic stones // New Engl. J.
Med.— 1986.—Vol.314.— P.248.

179. Multigner L., Sarles H., Lombardo D., DeCaro A. Pancreatic stone protein. I. Implications
in stone formation during the course of chronic pancreatitis // Gastroenterol.— 1985.—
Vol.89.—P.381.

180. Navarro S., Hidalgo J. M., Bessa X. et al. Intra-abdominal pressure (iap) as an predictive
factor of severity in acute pancreatitis // Gut.— 2003.—Vol. 52 (Suppl. VI).— P. 17.

181. Nonaka A., Manabe Т., Tamura K. et al. Organ specific ESR features in mouse main organs
and ESR application to the model of pancreatic disorders // Nippon. Geka. Gakkai
Zasshi.—1990.—Vol.91.—P.169-173.

182. Norman J. G. New approaches to acute pancreatitis: role of inflammatory mediators // Di­
gestion.- 1999.-Vol.60 (1).- P.57-60.

183. Oezcueruemez-Porsch M., Kunz D., Hardt P. D. et al. Diagnostic relevance of interleukin
pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis
// Dig. Dis. Sci.- 1998.-Vol. 43 (8).— P.1763—1769.

184. Okazaki K., Uchida K., Ohana M. et al. Autoimmune-related pancreatitis is associated with
autoantibodies and a Thl/Th2-type cellular immune response // Gastroenterol.— 2000 —
Vol. 118 (3).—P.573—581.

185. Opie E. L. The etiology of acute hemorrhagic pancreatitis // Bull. Johns Hopkins hosp.—
1901.-Vol.12.-182 p.

186. Opie E. L. The causes and varieties of chronic interstitial pancreatitis // Am. J. Med. Sci.—
1902.-Vol.123.-P.845.

187. Osman M. O., Kristensen J. U., Jacobsen N. O. et al. A monoclonal anti-interleukin 8 anti­
body (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute
necrotising pancreatitis in rabbits // Gut.— 1998.—Vol. 43 (2).— P. 232—239.

188. Otani Т., Chepilko S., GrendellJ., Gorelick F. Codistribution of TAP and the granule mem­
brane protein GRAMP-92 in rat caerulein-induced pancreatitis // Am. J. Physiol.—
1998.—Vol.275.— P.999—1009.

189. Pap A., Boros L. Alcohol-induced chronic pancreatitis in rats after temporary occlusion of
biliopancreatic ducts with ethibloc // Pancreas.— 1989.— Vol.4.— P.249—255.

190. Patard L., Lallemand J.-Y., Stoven V. An insight into the role of human pancreatic lithos-
tathine // JOP. J Pancreas (Online).- 2003.-Vol. 4 (2).- P.92-103.

191. Patthy L. Homology of human pancreatic stone protein with animal lectins // Biochem.
J.- 1988.-Vol. 253.— P.309—311.

192. Petersen Т. Е. The amino-terminal domain of thrombomodulin and pancreatic stone pro­
tein are homologous with lectins // FEBS Lett,— 1988.—Vol.231.— P.51—53.

193. Pezzilli R-, Miniero R., Cappelletti O., Barakat B. Serum Interleukin-6 in the prognosis of
acute biliary pancreatitis // Ital. J. Gastroenterol. Hepatol,— 1998.-Vol 30 (3).- P.29.

194. Pfeffer R. В., Stasior O., Hinton J. W. The clinical picture of the sequential development of
acute hemorrhagic pancreatitis in the dog // Surg. Forum.— 1957.— Vol.8.— P.248—251.

195. Pfutzer R., Barmada M., Brunskill A. et al. SPINK1/PSTI polymorphisms act as a disease
modifiers in familial and idiopathic chronic pancreatitis // Gastroenterol.— 2000.—
Vol.119.—P.615-623.

196. Pitchumoni С S., Viswanathan K. V., Gee Varghese P. J., Banks P. A. Ultrastructure and el­
emental composition of human pancreatic calculi // Pancreas.— 1987.— Vol.2.— P.152—
158.

197. Pitkaranta P., Kivisaari L., Nordting S. et al. Experimental chronic pancreatitis in the pig /
/ Scand. J. Gastroenterol.- 1989.— Vol.24.- P.987—992.

198. Powell J. J., Fearon K. C, Siriwardena A. K. et al. Evidence against a role for polymor-

166 • ХРОНИЧЕСКИЙ ПАНКРЕАТИТ

phism's at tumor necrosis factor? IL-1 and IL-1 receptor antagonist gene loci in the regu­lation of disease severity in acute pancreatitis // Surgery,— 2001.— Vol. 129 (5).— P. 633— 640.

199. Regan P. Т., Malagelada J. R., DiMagno E. P. et al. Comparative effects of antacids, cime-
tidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic
insufficiency // Dig. Dis. Sci.— 1982.-Vol.27.— P.485-490.

200. Regoly-Merei J., Kovacs G. C, Orgovan G. et al. Role of monocyte-lymphocyte system and
of endogenous mediators in the severity of acute pancreatitis and in development of its sep­
tic complications // Magy. Seb.— 2001,— Vol. 54 (5).— P.273—281. enner I. G., Rinderk-
necht H., Douglas A. P. Profiles of pure pancreatic secretions in patients with acute pancre­
atitis: The possible role proteolytic enzymes in pathogenesis // Gastroenterol.— 1978. —
Vol.75.— P. 1090—1098.

201. Roitt I., Brostoff J., Male D. Ed. Immunology.—5^th ed.—London: Mosby International
Ltd, 1998.

202. Sahel J., Sarles H. Modifications of pure human pancreatic juice induced by chronic alco­
hol consumption // Dig. Dis. Sci.— 1979.- Vol.24.— P.897—905.

203. Saito I., Hashimoto S., Saluja A. et al. Intracellular transport of pancreatic zymogens during
caerulein supramaximal stimulation // Am. J. Physiol.— 1987.—Vol.253.— P.517—526.

204. Sakakibara A., Okumura N., Hayakawa Т., Kanzaki M. Ultrastructural changes in the exo-
crine pancreas of experimental pancreatolithiasis in dogs // Am. J. Gastroenterol.— 1982.—
Vol.77.— P.498-503.

205. Sakorafas G. H., Tsiotou A. G. Etiology and pathogenesis of acute pancreatitis: current con­
cepts // J. Clin. Gastroenterol.— 2000.— Vol. 30 (4).— P.343—356.

206. Saluja A., Hashimoto S., Saluja M. et al. Subcellular redistribution of lysosomal enzymes
during caerulein-induced pancreatitis // Am. J. Physiol.— 1987.— Vol.253.— P.508—516.

207. Saluja A., Saluja M., Villa A. et al. Pancreatic duct obstruction in rabbits causes digestive
zymogen and lysosomal enzyme colocalization // J. Clin. Invest.— 1989.— Vol 84 —
P.1260—1266.

208. Saluja A. K., Steer M. L. Pathophysiology of pancreatitis: role of cytokines and other me­
diators of inflammation // Digestion,— 1999.— Vol.60 (Suppl. 1).— P.1260—1264.

209. Sarles H. Etiopathogenesis and definition of chronic pancreatitis // Dig. Dis. Sci.— 1986.—
Vol.31 (suppl.).— P.91—107.

210. Sarles H. Classificatin et determination des pancreatitis // Gastroent. Clin. Biol.— 1989 —
Vol. 13 (11).— P.857—859.

211. Sarles H., Barnard J. P., Chonson C. Pathogenesis and epidemiology of chronic pancreatitis
// Ann. Rev. Med.— 1989.—Vol.40.- P.453.

212. Sarles H., Bernard J. P. Lithostathine and pancreatic lithogenesis // Gastroenterol. Int. Ed.
Int.— 1991.—Vol.4.—P.130—134.

213. Saurer L., Reber P., Schaffner T. et al. Differential expression of chemokines in normal
pancreas and in chronic pancreatitis // Gastroenterol.— 2000 — Vol. 118 (2).—P.356—
367.

214. Schiesser M., Bimmler D., Frink T. W., Graf R. Conformational changes of pancreatitis-as­
sociated protein (PAP) activated by trypsin lead to insoluble protein aggregates // Pancre­
as,— 2001.- Vol.22.- P.186-192.

215. Schlosser W., Gansauge F., Schlosser S. et al. Low serum levels of CD44, CD44v6, and
neopterin indicate immune dysfunction in chronic pancreatitis // Pancreas,—2001.—
Vol. 23 (4).— P.335-340.

216. Schmiegel W., Burchert M., Kalthoff H. et al. Immunochemical characterization and quan­
titative distribution of pancreatic stone protein in sera and pancreatic secretions in pancre­
atic disorders // Gastroenterol.- 1990.- Vol.99.— P.1421.

217'. Schnlmerich J. Cytokines in inflammatory pancreatic disease // Gut.—1997.—Vol. 41 (suppl. 3).- P.75.

218. Selzman С H., Shames B. D., Miller S. A. et al. Therapeutic implications of interleukin-
10 in surgical disease // Shock.- 1998.-Vol. 10 (5).- P.309-318.

219. Shimizu Т., Shiratori K., Sawada T. et al. Recombinant human IL-1 T decreases severity of
acute necrotizing pancreatitis in mice // Pancreas.— 2000.— Vol. 21 (2).— P.134— 140.

220. Sholmerich J. Early parameters of prognosis in acute pancreatitis — can cytokine measure­
ments fulfil their promise? // Ital. J. Gastroenterol. Hepatol—1998.—Vol. 30 (3).—
P.295—296.

221. Shutt C, Zastrow R., Eggers G. et al. Immunstatus bei patient mit chronisher pankreatitis
/ Allergie und Immunolog.- 1980,- Bd 26 (3).- S. 22-42.

222. Simovic M. O., Bonham M. J., Abu-Zidan F. M., Windsor J. A. Anti-inflammatory cytokine

Глава 3. Универсальные патогенетические механизмы развития ХП • 167

response and clinical outcome in acute pancreatitis // Crit. Care Med.— 1999.— Vol. 27

(12).- P.2662-2665.

223. Slotwinski R., Slodkowski M, Pertkiewicz M. et al. Dynamic of IL-6 and IL-8 concentra­
tions in patients after surgery treated with total parenteral nutrition // Pol. Merkuriusz.
Lek.- 2002.- Vol. 12 (67).- P.45-48.

Дата добавления: 2015-10-21